1 month Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here’s What You Should Know Zacks X
1 month Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalner’s Epilepsy Potential Seeking Alpha X
1 month Recursion Pharmaceuticals (RXRX) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks X
1 month Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here’s Why a Trend Reversal May be Around the Corner Zacks X
1 month Down -9.11% in 4 Weeks, Here’s Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround Zacks X
1 month Regeneron Pharmaceuticals, Inc. (REGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript) Seeking Alpha X
1 month Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha X
1 month Does Recursion Pharmaceuticals (RXRX) Have the Potential to Rally 27.96% as Wall Street Analysts Expect? Zacks X
2 months Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks X
2 months West Pharmaceuticals: Cannot Wrap My Head Around Valuations (Rating Downgrade) Seeking Alpha X
2 months Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 Seeking Alpha X
2 months Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks X